UPDATE: KBW Downgrades DR Horton to Market Perform Following Q1 Earnings Report

In a research note Wednesday morning, Keefe, Bruyette & Woods downgraded DR Horton Inc. (NYSE: DHI ) from Outperform to Market Perform. Despite the ratings downgrade, the firm's Ryan Tomasello raised his price target from $23 to $25. The note follows DR Horton's Q1 results Tuesday morning before